In vivo synergy of daptomycin plus a penicillin agent for MSRA? [3]

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 3, 2005, Pages 398-399

  Scheetz, Marc ^a   Reddy, Pavani ^b   Postelnick, Michael ^a   Flaherty, John ^b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Lipopeptide; Methicillin resistant Staphylococcus aureus; Therapy

Indexed keywords

DAPTOMYCIN; GENTAMICIN; METICILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL GROWTH; CASE REPORT; CATHETER INFECTION; DRUG POTENTIATION; HUMAN; IN VIVO STUDY; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE;

DAPTOMYCIN; DRUG THERAPY, COMBINATION; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 15844380990     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh554     Document Type: Letter

References (7)

1. Karchmer, A. W. (1991). Staphylococcus aureus and vancomycin: the sequel. Annals of Internal Medicine 115, 739-41.
2. Stevens, D. L., Herr, D., Lampiris, H. et al. (2002). Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clinical Infectious Diseases 34, 1481-90.
3. Grohs, P., Kitzis, M. D. & Gutmann, L. (2003). In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 47, 418-20.
4. Brown, J. & Freeman, B. B., III (2004). Combining quinupristin/-dalfopristin with other agents for resistant infections. Annals of Pharmacotherapy 38, 677-85.
5. Tally, F. P., Oleson, F. B., Berman, C. L. et al. (2000). Daptomycin treatment of serious gram-positive infections. In Abstracts of the Tenth European Congress of Clinical Microbiology and Infectious Diseases, Stockholm, Sweden, 2000. Abstract WeP233:8/1. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
6. Fuchs, P. C., Barry, A. L. & Brown, S. D. (2002). In vitro bactericidal activity of daptomycin against staphylooocci. Journal of Antimicrobial Chemotherapy 49, 467-70.
7. Rand, K. H. & Houck, H. J. (2004). Synergy of daptomycin with oxacillin and other β-lactams against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 48 2871-5.